Probiotic products are products which contain probiotics; these are live non-pathogenic microorganisms which provide health benefits to the host when administered in adequate amounts. Currently the world is facing a climate change crisis which among other things, leads to alteration of the abundance, distribution and transmission of animal pathogens leading to increased incidences of animal diseases. Moreover, the world is facing a crisis of development of antimicrobial resistance (AMR) by many strains of pathogenic microorganisms. For many decades conventional technologies which have been used for control of infectious diseases in animals include vaccines, antimicrobials, acaricides, and antihelmintics. The AMR crisis has made antimicrobials not to be a reliable technology for control of some infectious diseases caused by pathogenic microorganisms. In attempts to look for alternative technologies other than vaccines, acaricides, and antihelmintics for control of infectious diseases in animals, many studies have been conducted to determine prophylactic efficacy of many strains of probiotics against the diseases. The objective of this paper is to review prophylactic efficacy of probiotic products against infectious animal diseases and provide insights on mechanisms of action of probiotics. Reports of prophylactic efficacy of probiotic products against animal diseases, and mechanisms of action of probiotics were searched using google search engine. After assessment of the reports; appropriate ones were selected, summarized, and globally synthesized. Many reports reporting significant prophylactic efficacy of probiotic products against infectious animal diseases were found. However, most studies focused on bacterial diseases of the digestive system. More studies focusing on bacterial, viral, and protozoal diseases of the digestive and other body systems of animals are recommended in order to get more data on the spectrum of activity of probiotics. Based on this review it is concluded that probiotic products have significant prophylactic efficacy against infectious animal diseases. The products are appropriate for use as alternative technologies to antimicrobials for control of infectious animal diseases in the AMR crisis. They are also appropriate for use in climate adapted livestock farming because apart from contributing to enhancement of animal health and productivity, they contribute to adaptation of some of the impacts of climate change in livestock farming (particularly increased incidences of animal diseases) by enhancing the resilience of livestock to diseases; and climate change mitigation by decreasing greenhouse gas intensity through enhanced animal health.
Read full abstract